Tumour-specific frequencies

Tumour-specific frequencies are specific electromagnetic frequencies that have been identified in patients with certain types of tumours and that can influence the growth and proliferation of tumour cells. These frequencies are unique to different tumour types and can be used to target tumour cells. Here are some important points about tumour-specific frequencies:

Identificationtumour-specific frequencies are identified through biofeedback-based methods in which patients with different tumour types respond to specific frequencies.

Uniquenessthese frequencies are specific to certain tumour types. For example, certain frequencies have only been found in patients with liver cancer (HCC) or breast cancer.

Therapeutic applicationthe identified frequencies are used to modulate electromagnetic fields, which are then transmitted into the patient's body. These modulated EMFs are intended to inhibit the growth of tumour cells and induce their cell death.

In-vitro and in-vivo studiesstudies have shown that tumour-specific frequencies can inhibit the growth of tumour cells in cell cultures. In clinical studies, therapeutic benefits have also been observed in patients with advanced cancer.

Examples of frequenciessome of the tumour-specific frequencies identified include 1,873,477 Hz, 2,221,323 Hz, 6,350,333 Hz and 10,456,383 Hz, which have been found in various tumour types such as breast cancer and liver cancer.

It is important to note that research on tumour-specific frequencies is still in its early stages and further studies are needed to fully understand their efficacy and safety.